Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Oncology R&D Pipeline

Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.

Programs 5,539

Quick answer

Oncology: NovaPharmaNews indexes 5,539 oncology clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Anticancer agents, immuno-oncology biologics, and oncology pipeline programs from ClinicalTrials.gov — Phase 1 through approval.

Top sponsors

Pipeline programs

Page 47 of 116

  1. ENMD-2076

    CASI Pharmaceuticals

    Ovarian Cancer

    phase 2 small molecule completed

    1 trial

  2. ENMD-2076

    CASI Pharmaceuticals

    Triple Negative Breast Cancer

    phase 2 small molecule completed

    1 trial

  3. EOF5

    Fudan University

    Gastric Cancer

    phase 2 small molecule completed

    1 trial

  4. EORTC 1612-MG

    Ningbo Cancer Hospital

    BRAF V600 mutation–positive unresectable or metastatic melanoma

    phase 2 small molecule active

    1 trial

  5. EORTC 1740-HNCG

    Ningbo Cancer Hospital

    Oropharyngeal Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  6. EORTC-1745-ETF-BCG

    Ningbo Cancer Hospital

    Localized ER+ breast cancer

    phase 2 small molecule active

    1 trial

  7. EP0042-101

    Lacuna Pharma Pty Ltd

    Acute Myeloid Leukaemia (AML), Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML)

    phase 2 small molecule active

    1 trial

  8. EP0062-101

    Lacuna Pharma Pty Ltd

    Breast Cancer

    phase 2 small molecule active

    1 trial

  9. EPI-7386, Xtandi - 40 mg soft capsules

    Lacuna Pharma Pty Ltd

    Metastatic castration-resistant prostate cancer

    phase 2 small molecule active

    1 trial

  10. ESR-17-13082

    Disc Medicine

    Locally advanced rectal cancer

    phase 2 small molecule active

    1 trial

  11. ET-20-049

    Lacuna Pharma Pty Ltd

    Patiens with locally advanced/metastatic endometrial carcinoma or cervix carcinoma progressing/relapsing after at least one prior systemic chemotherapy.

    phase 2 small molecule active

    1 trial

  12. ETOP 23-22 RAISE

    Partner Therapeutics Limited

    Extensive-disease small cell lung cancer and high SLFN11-expression

    phase 2 small molecule active

    1 trial

  13. Elacestrant

    Context Therapeutics

    Breast Cancer

    phase 2 small molecule terminated

    2 trials

  14. ElechtraPlatinum

    Istituto Gentili S.r.l.

    relapsing vulvar carcinoma already subjected to multiple treatments

    phase 2 small molecule active

    1 trial

  15. Elironrasib

    Revolution Medicines

    Non-Small Cell Lung Cancer (NSCLC)

    phase 2 small molecule active

    1 trial

  16. Embrace-III Hi-Risk

    Disc Medicine

    high risk or poor response after chemoradiation and brachytherapy for locally advanced cervix cancer

    phase 2 small molecule active

    1 trial

  17. EmpowHER 208

    Jazz Pharmaceuticals Ireland Limited

    HER2-positive breast cancer

    phase 2 small molecule active

    1 trial

  18. Enasidenib

    Agios Netherlands B.V.

    Hematologic Neoplasms

    phase 2 small molecule completed

    1 trial

  19. Enasidenib Mesylate

    Jazz Pharmaceuticals Ireland Limited

    Recurrent Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  20. Encorafenib + Binimetinib

    Regeneron UK Limited

    Melanoma BRAF V600E/K Mutated

    phase 2 small molecule active

    1 trial

  21. Endostar

    The First People's Hospital of Lianyungang

    Esophageal Cancer

    phase 2 small molecule active

    1 trial

  22. Endostar

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Neoplasms

    phase 2 small molecule active

    2 trials

  23. Endostatins

    The First People's Hospital of Lianyungang

    Nasopharyngeal Carcinoma

    phase 2 small molecule active

    1 trial

  24. Enfortumab vedotin

    United Therapeutics Europe Ltd

    Metastatic Urothelial Carcinoma

    phase 2 small molecule active

    1 trial

  25. Engineered Mitochondrial Vaccine (IMP3-Mito)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Head and Neck Squamous Cell Carcinoma

    phase 2 mab active

    1 trial

  26. Ensartinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  27. Ensartinib

    The First People's Hospital of Lianyungang

    Solid Tumors

    phase 2 small molecule active

    1 trial

  28. Entinostat

    Syndax Pharmaceuticals

    Non-Small-Cell Lung Carcinoma

    phase 2 small molecule completed

    1 trial

  29. Entinostat

    Syndax Pharmaceuticals

    Melanoma

    phase 2 small molecule completed

    1 trial

  30. Entinostat

    Syndax Pharmaceuticals

    Non Small Cell Lung Cancer

    phase 2 small molecule terminated

    2 trials

  31. Entinostat

    Syndax Pharmaceuticals

    Renal Cell Carcinoma

    phase 2 small molecule active

    2 trials

  32. Entinostat

    Syndax Pharmaceuticals

    ER+ Breast Cancer

    phase 2 small molecule completed

    1 trial

  33. Entinostat

    KYOWA KIRIN AUSTRALIA PTY LTD

    Advanced or Recurrent Breast Cancer

    phase 2 small molecule completed

    1 trial

  34. Entinostat

    Syndax Pharmaceuticals

    Metastatic Cholangiocarcinoma

    phase 2 small molecule completed

    1 trial

  35. Entinostat

    Syndax Pharmaceuticals

    Lymphoma

    phase 2 small molecule active

    1 trial

  36. Entinostat

    Syndax Pharmaceuticals

    Hodgkin's Lymphoma

    phase 2 small molecule terminated

    1 trial

  37. Entrectinib

    Hoffmann-La Roche

    Solid Tumors

    phase 2 small molecule active

    1 trial

  38. Entrectinib

    Hoffmann-La Roche

    Breast Cancer

    phase 2 small molecule active

    1 trial

  39. Envafolimab

    The First People's Hospital of Lianyungang

    Metastatic Colorectal Cancer

    phase 2 small molecule active

    1 trial

  40. Envafolimab

    The First People's Hospital of Lianyungang

    Gastric Cancer

    phase 2 small molecule active

    1 trial

  41. Envafolimab Injection

    The First People's Hospital of Lianyungang

    Gastrointestinal Neoplasms

    phase 2 small molecule active

    1 trial

  42. Enzalutamide

    CORCEPT THERAPEUTICS INC

    Metastatic Breast Cancer

    phase 2 small molecule active

    1 trial

  43. Enzalutamide

    BRIGHT MINDS BIOSCIENCES INC.

    Prostate Cancer Metastatic

    phase 2 small molecule completed

    1 trial

  44. Enzalutamide 40mg

    United Therapeutics Europe Ltd

    Metastatic Castration-Resistant Prostate Cancer (mCRPC)

    phase 2 small molecule active

    1 trial

  45. Epcoritamab

    United Therapeutics Europe Ltd

    Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

    phase 2 mab active

    1 trial

  46. Epcoritamab

    ADC Therapeutics SA

    Large B-cell Lymphoma

    phase 2 small molecule active

    1 trial

  47. Epcoritamab for DIFFUSE LARGE B CELL LYMPHOMA

    Genmab A/S

    DIFFUSE LARGE B CELL LYMPHOMA

    phase 2 small molecule active

    1 trial

  48. Epstein-Barr virus-specific cytotoxic T lymphocytes (EBV-CTLs)

    Evidence Based Cataract Study Group

    EBV-induced Lymphomas

    phase 2 mab completed

    1 trial

Frequently asked questions

How many oncology pipeline programs are tracked?

5,539 programs match this therapeutic area based on indication text, program name, and registry metadata.

Where does pipeline data come from?

ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.